5-carboxyfluorescein diacetate and rhodamine 123

5-carboxyfluorescein diacetate has been researched along with rhodamine 123 in 1 studies

Compound Research Comparison

Studies (5-carboxyfluorescein diacetate)	Trials (5-carboxyfluorescein diacetate)	Recent Studies (post-2010) (5-carboxyfluorescein diacetate)	Studies (rhodamine 123)	Trials (rhodamine 123)	Recent Studies (post-2010) (rhodamine 123)
41	0	13	1,760	10	424

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Asano, T; Fukunaga, Y; Matsunaga, S; Tsutsuda-Asano, A	1

Other Studies

1 other study(ies) available for 5-carboxyfluorescein diacetate and rhodamine 123

Article	Year
Indomethacin overcomes doxorubicin resistance with inhibiting multi-drug resistance protein 1 (MRP1). Cancer chemotherapy and pharmacology, 2006, Volume: 58, Issue:3 Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Survival; Cyclooxygenase Inhibitors; Doxorubicin; Drug Resistance, Neoplasm; Fluoresceins; Humans; Indomethacin; K562 Cells; Multidrug Resistance-Associated Proteins; Promoter Regions, Genetic; Prostaglandin-Endoperoxide Synthases; Rhodamine 123; RNA, Messenger	2006

Article

Year

Indomethacin overcomes doxorubicin resistance with inhibiting multi-drug resistance protein 1 (MRP1).

Cancer chemotherapy and pharmacology, 2006, Volume: 58, Issue:3

Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Survival; Cyclooxygenase Inhibitors; Doxorubicin; Drug Resistance, Neoplasm; Fluoresceins; Humans; Indomethacin; K562 Cells; Multidrug Resistance-Associated Proteins; Promoter Regions, Genetic; Prostaglandin-Endoperoxide Synthases; Rhodamine 123; RNA, Messenger

2006